Clinical Overview of Omacor: A Concentrated Formulation of Omega-3 Polyunsaturated Fatty Acids

This publication has 17 references indexed in Scilit:

• An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia
  Heart, 2001
• The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertrygliceridemia
  Atherosclerosis, 2000
• Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n−3 fatty acids
  The American Journal of Clinical Nutrition, 2000
• Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses
  Atherosclerosis, 2000
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial
  The Lancet, 1999
• n-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study
  Journal of the American College of Cardiology, 1999
• Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins
  Atherosclerosis, 1999
• Soluble Cell Adhesion Molecules in Hypertriglyceridemia and Potential Significance on Monocyte Adhesion
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency
  The American Journal of Cardiology, 1996
• Improvement of serum lipids and blood pressure during intervention with n‐3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia
  Journal of Internal Medicine, 1995